LAVAL, Quebec, Sept. 10, 2020 /CNW/ -- The Bausch Foundation
("Foundation"), which oversees and directs the charitable giving
efforts of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch
Health"), today released its Inaugural Activity Report, which
highlights the efforts of the Foundation from late 2017 through
June 30, 2020. The Bausch Foundation
aims to improve the lives of patients globally by providing access
to safe, effective medicines and by financially supporting health
care education and causes.
"The Bausch Foundation is an extension of Bausch Health – the
Foundation helps us achieve our mission of improving people's lives
with our health care products by enabling us to approach
philanthropy in a more strategic and impactful manner. In 2018 and
2019, Bausch Health donated approximately $600 million1 worth of pharmaceutical
products to assist patients with financial hardship, including
products distributed by the Foundation for global mission trips and
natural disaster support efforts," said Joseph C. Papa, chairman and CEO, Bausch Health.
"Corporate philanthropy is now more important than ever, and we
are proud to release this inaugural report to highlight the efforts
of the Foundation to date. With the support of our philanthropic
partners and Bausch Health's more than 22,000 employees, I am
confident we can build upon these initial efforts to make a
meaningful difference in people's lives."
The Bausch Foundation supports initiatives in four core areas of
focus, including:
- Disease prevention;
- Improving patient outcomes and lives;
- Education and community support related to our core businesses;
and
- Support for global relief efforts and those who need help in
the communities in which we live and work.
The full report can be viewed in the Responsibility section of
Bausch Health's website at
https://www.bauschhealth.com/responsibility.
About the Bausch Foundation
The Bausch Foundation was
established in 2017 to improve the lives of patients globally by
providing access to safe, effective medicines and by financially
supporting health care education and causes. Since its
inception, the Bausch Foundation has contributed millions of
dollars' worth of financial and product donations to charitable
health organizations.
About Bausch Health
Bausch Health Companies Inc.
(NYSE/TSX: BHC) is a global company whose mission is to improve
people's lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device
and over-the-counter products, primarily in the therapeutic areas
of eye health, gastroenterology and dermatology. We are delivering
on our commitments as we build an innovative company dedicated to
advancing global health. More information can be found at
www.bauschhealth.com.
Forward-looking Statements
This news release may
contain forward-looking statements, which may generally be
identified by the use of the words
"anticipates," "expects," "intends," "plans," "should," "could," "would," "may,"
"believes," "estimates," "potential," "target," or "continue" and
variations or similar expressions. These statements are based upon
the current expectations and beliefs of management and are subject
to certain risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. These risks and uncertainties include, but are not
limited to, the risks and uncertainties discussed in Bausch
Health's most recent annual report on Form 10-K and detailed from
time to time in Bausch Health's other filings with the U.S.
Securities and Exchange Commission and the Canadian Securities
Administrators, which factors are incorporated herein by reference.
They also include, but are not limited to, risks and uncertainties
caused by or relating to the evolving COVID-19 pandemic, and the
fear of that pandemic and its potential effects, the severity,
duration and future impact of which are highly uncertain and cannot
be predicted, and which may have a material adverse impact on
Bausch Health, including but not limited to its project development
timelines, and costs (which may increase). Readers are cautioned
not to place undue reliance on any of these forward-looking
statements. These forward-looking statements speak only as of the
date hereof. Bausch Health undertakes no obligation to update any
of these forward-looking statements to reflect events or
circumstances after the date of this news release or to reflect
actual outcomes, unless required by law.
1 Calculated using the wholesale acquisition
cost (WAC) of each product.
Investor
Contact:
|
Media
Contact:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@bauschhealth.com
|
lainie.keller@bauschhealth.com
|
(514)
856-3855
|
(908)
927-1198
|
(877) 281-6642 (toll
free)
|
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bausch-foundation-releases-inaugural-activity-report-301127307.html
SOURCE Bausch Health Companies Inc.